Home › Funds › Citadel Advisors › ROIV
Citadel Advisors position in ROIV
ROIVANT SCIENCES LTD · Health Care
Latest position (Q2 2026)5.81M sh
Reported value held$205.73M
Portfolio Weight0.02%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 222.95K | $907.00K | New |
| Q3 2022 | 1.50M | $4.82M | Add |
| Q4 2022 | 955.57K | $7.64M | Reduce |
| Q1 2023 | 1.47M | $10.85M | Add |
| Q2 2023 | 98.48K | $992.67K | Reduce |
| Q3 2023 | 280.90K | $3.28M | Add |
| Q4 2023 | 3.75M | $42.08M | Add |
| Q1 2024 | 3.50M | $36.84M | Reduce |
| Q2 2024 | 2.22M | $23.48M | Reduce |
| Q3 2024 | 6.28M | $72.44M | Add |
| Q4 2024 | 2.09M | $24.76M | Reduce |
| Q1 2025 | 1.72M | $17.38M | Reduce |
| Q2 2025 | 822.03K | $9.26M | Reduce |
| Q3 2025 | 1.48M | $22.39M | Add |
| Q4 2025 | 2.97M | $64.38M | Add |
| Q1 2026 | 2.72M | $75.43M | Reduce |
| Q2 2026 | 5.81M | $205.73M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ROIV
- Fidelity Management & Research (FMR) 81.02M sh · $2.87B · Q2 2026
- BlackRock Inc 48.24M sh · $1.71B · Q2 2026
- Morgan Stanley 42.59M sh · $1.51B · Q2 2026
- Vanguard Group 42.06M sh · $912.68M · Q4 2025
- Goldman Sachs Group 18.56M sh · $656.71M · Q2 2026
- UBS Group AG 17.47M sh · $618.14M · Q2 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- Geode Capital Management 11.67M sh · $425.54M · Q2 2026
- Wells Fargo & Co 9.72M sh · $344.04M · Q2 2026
- Invesco Ltd 7.53M sh · $266.53M · Q2 2026
- AQR Capital Management 6.63M sh · $234.03M · Q2 2026
- Viking Global Investors 6.27M sh · $221.95M · Q2 2026